JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer

L. Pangon*, I. Ng, M. Giry-Laterriere, N. Currey, A. Morgan, F. Benthani, P. N. Tran, S. Al-Sohaily, E. Segelov, B. L. Parker, M. J. Cowley, D. C. Wright, L. St Heaps, L. Carey, I. Rooman, M. R. J. Kohonen-Corish

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Citations (Scopus)

Fingerprint

Dive into the research topics of 'JRK is a positive regulator of β-catenin transcriptional activity commonly overexpressed in colon, breast and ovarian cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences